科研之友
微信
新浪微博
Facebook
分享链接
摘要
1文献来源Kindler HL, Novello S, Bearz A, et al.Anetumab ravtansine versus vinorelbine in patients with relapsed,mesothelin-positive malignant pleural mesothelioma(ARCS-M):a randomised,open-label phase 2 trial[J]. Lancet Oncol,2022,23(4):540-552.
- 单位
1文献来源Kindler HL, Novello S, Bearz A, et al.Anetumab ravtansine versus vinorelbine in patients with relapsed,mesothelin-positive malignant pleural mesothelioma(ARCS-M):a randomised,open-label phase 2 trial[J]. Lancet Oncol,2022,23(4):540-552.
